Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)
Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)
Recruiting · NCT07136857 · Registry updated 2025-12-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Glanzmann thrombasthenia 1, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Recruiting | Phase 2 | 2025-12-01 | NCT07136857 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Emory University | 393 |
| Laboratoire français de Fractionnement et de Biotechnologies | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arthur M. Blank Hospital | Children's Healthcare of Atlanta | Atlanta | United States | 4 |